Profound Medical Corp has seen a notable uptick in its stock price, gaining over 3% in the last trading session.
On the TSX, Profound Medical Corp (PRN.TO) experienced a positive trading day, closing at CA$9.64, reflecting a 3.21% increase. This rise comes amidst a backdrop of strategic financial maneuvers that could bolster the company's growth prospects.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$365.19M
52W high
$12.40
52W low
$5.23
1W change
-2.87%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 146.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+146.4% Upside
Current Price
C$10.16
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
42.5%
Annualized
90-Day Vol
82.2%
Annualized
Trend (90d)
+45.4%
Annualized drift
90d Mean
C$11.95
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$10.72 | C$9.26 โ C$12.42 |
| 60 trading days | C$11.32 | C$9.20 โ C$13.93 |
| 90 trading days | C$11.95 | C$9.26 โ C$15.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: As Profound Medical Corp continues to expand its financial base through recent offerings, investors may find this upward momentum encouraging, especially given the company's strong revenue growth reported in previous quarters.
Profound Medical Corp sees a 3.21% increase in stock price
The stock closed at CA$9.64, reflecting growing investor confidence following recent financial developments.
Bull case
The recent closing of a $36 million registered direct offering positions Profound Medical Corp to enhance its operational capabilities and pursue further growth opportunities. With a robust Q3 revenue report showing an 87% year-over-year increase, the stock's momentum may continue as investor confidence builds.
Bear case
Despite the positive movement, investors should stay cautious. The lack of consistent profitability, indicated by a negative profit margin, raises concerns about the long-term sustainability of this growth. Additionally, market volatility could affect future performance.
Recent Financial Developments
Profound Medical recently closed a $36 million registered direct offering, which is expected to enhance its financial flexibility. This strategic move is anticipated to support future growth initiatives and strengthen its market position.
Strong Revenue Performance
The company reported a remarkable 87% increase in revenue for Q3 2025, reaching approximately $5.3 million. This performance highlights the effectiveness of its business strategies and may attract further investor interest.
Market Outlook
While the recent gains are promising, potential investors should consider the company's negative profit margin and the inherent risks of investing in smaller-cap stocks like Profound Medical Corp. Monitoring upcoming financial results will be crucial for assessing ongoing performance.
Advertisement
